Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Dressman

Showing results (41-50 of 124) with videos related to

Pageof 13
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 30, 2020
Prediction of plasma profiles of a weakly basic drug after administration of omeprazole using PBPK modelingDomagoj Segregur, James Mann, Andrea Moir, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 17, 2019
Calculation of drug-polymer mixing enthalpy as a new screening method of precipitation inhibitors for supersaturating pharmaceutical formulationsDaniel J Price, Anita Nair, Martin Kuentz, et al.
Journal of Pharmaceutical Sciences|July 2, 2011
Are counterfeit or substandard anti-infective products the cause of treatment failure in Papua New Guinea?Anita Nair, Stefanie Strauch, Jackson Lauwo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 30, 2019
Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: NaproxenIoannis Loisios-Konstantinidis, Rodrigo Cristofoletti, Nikoletta Fotaki, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 23, 2025
Corrigendum to "Characteristics of contents in the upper gastrointestinal lumen after a standard high-calorie high-fat meal and implications for the in vitro drug product performance testing conditions" [Eur J Pharm Sci. 155 (2020) 105535]Christina Pentafragka, Maria Vertzoni, Jennifer Dressman, et al.
Journal of Pharmaceutical Sciences|May 11, 2020
Biorelevant Two-Stage In Vitro Testing for rDCS Classification and in PBPK Modeling-Case Example RitonavirTom Fiolka, Jens Van Den Abeele, Patrick Augustijns, et al.
The Journal of Pharmacy and Pharmacology|September 12, 2018
The impact of food intake on the luminal environment and performance of oral drug products with a view to in vitro and in silico simulations: a PEARRL reviewChristina Pentafragka, Mira Symillides, Mark McAllister, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 23, 2015
In vitro biorelevant models for evaluating modified release mesalamine products to forecast the effect of formulation and meal intake on drug releaseCord J Andreas, Ying-Chen Chen, Constantinos Markopoulos, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 3, 2020
Characteristics of contents in the upper gastrointestinal lumen after a standard high-calorie high-fat meal and implications for the in vitro drug product performance testing conditionsChristina Pentafragka, Maria Vertzoni, Jennifer Dressman, et al.
Journal of Pharmaceutical Sciences|September 21, 2019
Integrating Drug- and Formulation-Related Properties With Gastrointestinal Tract Variability Using a Product-Specific Particle Size Approach: Case Example IbuprofenRodrigo Cristofoletti, Bart Hens, Nikunjkumar Patel, et al.
Pageof 13

Showing results (41-50 of 124) with videos related to

Sort By:
Pageof 13
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 30, 2020
Prediction of plasma profiles of a weakly basic drug after administration of omeprazole using PBPK modelingDomagoj Segregur, James Mann, Andrea Moir, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 17, 2019
Calculation of drug-polymer mixing enthalpy as a new screening method of precipitation inhibitors for supersaturating pharmaceutical formulationsDaniel J Price, Anita Nair, Martin Kuentz, et al.
Journal of Pharmaceutical Sciences|July 2, 2011
Are counterfeit or substandard anti-infective products the cause of treatment failure in Papua New Guinea?Anita Nair, Stefanie Strauch, Jackson Lauwo, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 30, 2019
Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: NaproxenIoannis Loisios-Konstantinidis, Rodrigo Cristofoletti, Nikoletta Fotaki, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 23, 2025
Corrigendum to "Characteristics of contents in the upper gastrointestinal lumen after a standard high-calorie high-fat meal and implications for the in vitro drug product performance testing conditions" [Eur J Pharm Sci. 155 (2020) 105535]Christina Pentafragka, Maria Vertzoni, Jennifer Dressman, et al.
Journal of Pharmaceutical Sciences|May 11, 2020
Biorelevant Two-Stage In Vitro Testing for rDCS Classification and in PBPK Modeling-Case Example RitonavirTom Fiolka, Jens Van Den Abeele, Patrick Augustijns, et al.
The Journal of Pharmacy and Pharmacology|September 12, 2018
The impact of food intake on the luminal environment and performance of oral drug products with a view to in vitro and in silico simulations: a PEARRL reviewChristina Pentafragka, Mira Symillides, Mark McAllister, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 23, 2015
In vitro biorelevant models for evaluating modified release mesalamine products to forecast the effect of formulation and meal intake on drug releaseCord J Andreas, Ying-Chen Chen, Constantinos Markopoulos, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 3, 2020
Characteristics of contents in the upper gastrointestinal lumen after a standard high-calorie high-fat meal and implications for the in vitro drug product performance testing conditionsChristina Pentafragka, Maria Vertzoni, Jennifer Dressman, et al.
Journal of Pharmaceutical Sciences|September 21, 2019
Integrating Drug- and Formulation-Related Properties With Gastrointestinal Tract Variability Using a Product-Specific Particle Size Approach: Case Example IbuprofenRodrigo Cristofoletti, Bart Hens, Nikunjkumar Patel, et al.
Pageof 13